How often does Journey Medical move more than the options market prices?

0 of the last 4 reports moved at least as far as the implied move.

DERMNasdaqPharmaceutical Preparations

Journey Medical Corp (DERM) earnings date, market-implied expected move, and options open interest by expiry

4.74

+0.10 · +2.18%

Regular session13:29 ET

Open4.62Volume217,174Mkt cap$131.0MEPS-0.22

Day4.62 – 4.74100%52-wk4.31 – 9.568%

DERM

Journey Medical Corp

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Expected move

Inputs

Next report

Nov 11

after close · in 7 days

est.Q3 FY26

Calendar

Next report

Last report

+3.42%

vs ±84.3% implied · ×0.04

shaded = implied · ▲▼ = realized

Aug 12 '26 · confirmed

Implied vs realized

Largest filed tie

—

Supply chain

13F top-10 QoQ

+1.76%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

71 managers

Top fund weight

0.00%

DERM weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Journey Medical (DERM) is expected to report on Nov 11 after close (estimated date).

Implied vs realized

8 reports

0 of 4≥ implied

avg implied: ±63.4%
avg realized: ±17.8%

Feb 5 '25Feb 5 '25confirmed—▼−5.30%—

Mar 26 '25Mar 26 '25confirmed—▼−3.58%—

May 14 '25May 14 '25confirmed—▲+18.93%—

Aug 12 '25Aug 12 '25confirmed—▼−15.11%—

Q3 FY25Nov 12 '25confirmed±56.7%▼−15.31%×0.27

Q1 FY26Mar 25 '26confirmed±87.6%▼−30.01%×0.34

May 13 '26May 13 '26confirmed±25.1%▲+22.35%×0.89

Q2 FY26Aug 12 '26confirmed±84.3%▲+3.42%×0.04

quarterimplied−90%0+90%realized×

Q2 FY26±84.3%▲+3.42%×0.04

May '26±25.1%▲+22.35%×0.89

Q1 FY26±87.6%▼−30.01%×0.34

Q3 FY25±56.7%▼−15.31%×0.27

Aug '25—▼−15.11%—

May '25—▲+18.93%—

2 older reports

Mar '25—▼−3.58%—

Feb '25—▼−5.30%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 2 expiries · Nov 3 close

0.13OI · 2 expiries · Nov 3 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

280%Nov 2016d2170%

8+14%Feb 19107d0.001,8030%0.00

ExpiryPutsCallsP/C

Nov 2016d280%2170%0.13

Feb 19107d8+14%1,8030%0.00

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−1.69%as filednet margin · revenue +15.97% QoQ · +23.33% YoY

Revenue$19M+15.97%

Gross profit$12M66.81%+26.93%

Operating income$456,0002.46%+130.56%

Pre-tax income−$297,000+86.68%

Net income−$312,000−1.69%+86.01%

Cost of revenue$6M−1.21%

Operating expenses$12M+6.02%

Tax$15,000—

Other expense−$753,000−2.03%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ down · bars = volume, 15mSource: market data · 13:15 ET

Intraday

Event sensitivity

PCE ×1.07· ±3.6% vs ±3.3% · 19 releases

eventrelease day|move|up · n×base

PCEpersonal income & outlays±3.6%13 of 19×1.07

CPROFcorporate profits±3.3%6 of 12×0.99

PPIproducer prices±3.3%5 of 10×0.98

FOMCrate decision±3.1%10 of 24×0.93

GDPgross domestic product±2.9%10 of 19×0.87

CPIconsumer prices±1.6%8 of 10×0.48

NFPjobs report±1.5%3 of 10×0.45

Bar = avg |move| to ±4% · tick = ±3.3% avg day · ×base = |move| ÷ ±3.3% · min 6 releases

Earnings history

EPS -0.01 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 12 '26 · confirmed	-0.01	—
Q1 FY26	Mar 25 '26 · confirmed	-0.08	—
Q3 FY25	Nov 12 '25 · confirmed	-0.09	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod